Processa Pharmaceuticals, Inc. Other Receivables, Net, Current
Processa Pharmaceuticals, Inc. (PCSA) had Other Receivables, Net, Current of $22.30 thousand as of 2024-03-31, per its 10-Q filed 2024-05-10.
Discontinued › Notes › Nontrade Receivables
us-gaap:OtherReceivablesNetCurrent · last filed 2024-05-10
- 2024-03-31: Other Receivables, Net, Current $22.30K.
- 2016-09-30: Other Receivables, Net, Current $25.00K.
- 2016-06-30: Other Receivables, Net, Current $25.00K.
- 2016-03-31: Other Receivables, Net, Current $25.00K.
| Period end | Other Receivables, Net, Current |
|---|---|
| 2024-03-31 | $22.30K 10-Q · filed 2024-05-10 |
| 2016-09-30 | $25.00K 10-Q · filed 2017-09-08 |
| 2016-06-30 | $25.00K 10-Q · filed 2017-08-30 |
| 2016-03-31 | $25.00K 10-Q · filed 2017-08-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |